Dow Gains 423 Points as Wall Street Ends Week Higher

U.S. stocks advanced Friday as technology shares recovered from a recent sell-off, helping the major indexes finish the week higher amid elevated Treasury yields, volatile oil prices, and concerns about artificial intelligence investments. The Dow Jones Industrial Average led the gains, rising 423.31 points, or 0.83%, to close at 51,654.95, while investors assessed developments in global fuel supplies and the outlook for corporate earnings.

The S&P 500 gained 0.59% to 7,811.54, and the Nasdaq Composite rose 0.64% to 27,366.17, according to CNBC's market coverage. For the week, the Dow advanced 0.9%, the S&P 500 gained approximately 1.2%, and the Nasdaq increased 0.6%.

Stocks reached their session highs after President Donald Trump announced that Russian President Vladimir Putin had agreed to supply diesel to international markets, including the United States. West Texas Intermediate crude futures settled near $92 a barrel, while Brent crude futures finished above $104, with prices easing slightly after the announcement.

According to CNBC, Trump said Russia would initially supply more than 300,000 tons of diesel, followed by 500,000 tons in November and another 1 million tons afterward. He also outlined a further delivery of 3 million tons, conditional on the state of Russian refineries. Fuel supplies have faced pressure from attacks on Russian refineries and disruptions affecting energy infrastructure in the Middle East.

Technology shares led Friday's recovery following losses in the previous session. Palo Alto Networks gained 5%, CrowdStrike rose 4%, and Palantir Technologies advanced 5%. Microsoft added 2%, while Amazon climbed 3%, according to CNBC.

SpaceX shares rose 1% after the company announced an agreement to acquire a nationwide spectrum portfolio. Telecommunications stocks moved in the opposite direction as investors considered the potential competitive impact. Verizon fell more than 9% during afternoon trading, putting it on track for its steepest daily decline since July 22, 2002, when it lost nearly 12%.

The rebound followed Thursday's technology-led decline, when the Nasdaq fell more than 1%, marking its largest one-day loss since mid-August. The sell-off intensified concerns about artificial intelligence valuations after CNBC reported that OpenAI had told investors its annualized revenue reached $50 billion at the end of September. A previously reported $68 billion figure also included gross revenue from partners, according to a person familiar with the matter.

Adam Crisafulli of Vital Knowledge attributed the weakness to market positioning and mounting concerns about financing across the artificial intelligence sector.

"The sell-off reflected extreme positioning imbalances that have further to unwind in our view, which is why the whole AI-linked tech stock complex is unlikely to simply stage a sharp, V-shaped rebound," wrote Adam Crisafulli of Vital Knowledge.

Crisafulli also argued that questions about the business models of independent frontier artificial intelligence laboratories and growing resistance to additional sector financing were more significant concerns than differences between gross and net revenue figures.

Healthcare shares also contributed to Friday's gains. Merck and Gilead Sciences each advanced more than 2%, while Moderna and Novavax rose amid optimism about a reported National Institutes of Health initiative to accelerate personalized cancer vaccine development.

The New York Times reported that the NIH program was expected to begin in December, targeting pancreatic, liver, and colorectal cancers, as well as certain pediatric tumors. Several experimental treatments use messenger RNA technology to train the immune system to recognize proteins specific to tumors. Moderna is developing a personalized mRNA cancer vaccine with Merck.

Despite the weekly gains, longer-term Treasury yields reaching fresh 24-year highs remained a concern for investors. Michael Monaghan of Founder ETFs maintained a constructive outlook for equities through year-end, citing anticipated corporate growth, but warned that geopolitical tensions and their effects on energy prices could weigh on markets.

Monaghan said the conflict in the Middle East remained a constraint on market performance despite the near-term earnings outlook.

"A more violent, more kinetic, more border-expanding war is not priced into the market," the portfolio manager told CNBC.

Investors were preparing for a busier earnings calendar the following week, when major banks and companies including Johnson & Johnson and UnitedHealth were scheduled to report results on Tuesday, alongside Wells Fargo and Citigroup.